financial well five results the years thank you, are as website, full dollars have made been SEC and right, reviewing US Casey. in SEDAR. All the the as available results all In on
during the equates generated $XX.X of first first XXXX million XXXX, compared increase. net quarter business of of core revenue as to revenues an Our XX% which million net the to quarter $XX.X in of
Our the for sequential business growth core was X%.
major seen oxygen. We again have and our once growth PAPs, lines being vents, product solid in
an therefore in opportunities quarter, down we short these with this up still pursue unit million vaccine tracing the our approximately in a first continue the sources, our we generated quarter $X.X from place have the revenue it or during at period, time, will established of primarily very the revenue in center. can During to generated call other future. We scale
margin percentages, very influenced and primarily our both and healthy, are gross again core Our EBITDA, are once business. by
notional influence the these growth is our lines priority be margin percentages, main product might but business. some As there on continue for the to diversify, the
XX.X% at Our came gross XX.X%, and EBITDA margins during in and the quarter accordingly.
quarter $XX.X million EBITDA first and and gross came in amounts Our at respectively. $X.X
sleep continue from our these We to by products. ongoing are once rapid growth businesses they as national the rollout benefit again our oxygen encouraged of and of
Our of XX% revenue as core approximately from of XX% XXXX. first first vents quarter in to our quarter the revenue, compared was
the our but the revenue time, Importantly, to beginning each has more during is quarter. more product diversification show grown up and vent same
Our the of compared to in million first million approximately $XX.X $XX.X as quarter SG&A for quarter the ‘XX. totaled
some have seen preserve SG&A, have effects We margins. expenses inflationary the managed but on and
more around our to growth hiring the people and continue to country to expect model serve We organic new areas. patients expand
seen traveling on we pressures clinicians As the continues have the in to decrease need previously people. for a discussed, our abate. Therefore,
superior to which folks professional the our our We to has successful key seek clinicians and business always organic to help support been out continue efforts.
For the was CapEx on The our capital approximately million expenditures. quarter, out fleet. we spread across product invested $X
group. continued supplier we As a have to grow areas all through diversified
flow, continue We this cash have million stay sheet that that strategic an working sometimes managed quarter. to funded certain market a cases, we $XX.X prepay is to XX, share. increase serve the products for giving we in of us with and quantities, strengthened issues but the base. in balance of have purchasing chain We to March and feel This supply we through our goods, ability our during larger patient and of all will CapEx discretionary growing $XX.X we again means million. capital of once buy cash balance also the in At had comfortable overall to and front
which needed term executing all very once gives company tools on and buybacks. stayed of the to remains and begun Our We our underleveraged, and through efforts. us organic inorganic total debt have the long company grow million, $X.X at the significantly stock again we grown our have
As approved efforts disclosed previously on mentioned, the began board buyback our buyback. we stock
plan. available had a we X of of of total shares so million buying to purchased on to the XX, good out were We back able March start. March As shares off we're XXX,XXX XX, begin under approximately the
does discussed, business buyback opportunities sacrificing of this but the we the not As capital our of deployment, mean that in previously are ranks growth. has risen
organically while able at our continued looking to this to and opportunities We have count. have reducing share accomplish and grow are been simultaneously inorganic
Moving the our claims. issue and NIV related to on CMS OIG to
to and the appeal work assess audited medical to continuing of patients process contractors We its are CMS necessity through the by with the OIG.
QIC quarter are of independent our review claims. fourth individualized XX review We review. this on results receiving during and final the from are round more again of back in filed call, with will discussed review their the hopeful days anticipate this awaiting next these last have As clinical the once we and a
provided the we've to in related to revenue quarter, $XXX,XXX have revenue and core approximately net range to two of $XX.X pandemic. COVID-XX Moving business, related guidance the our second also $XX.X on million to the to guided
guided revenue the core to XX% quarter second is organic XXXX. XX% of Our over up
seen have be we growth the encouraged the COVID revenue We continue to as diminish. effects core by
both visiting I'll conferences to We wrap have sell current roadshows up. ongoing time, things the prospective from appreciate to turn relationships. year. industry investors this analysts support over back At side We and it the and and and with banking this with our non-deal existing been Casey buy again during the through once